Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 35

1.

The Friction Properties of Firebrat Scales.

Hirai Y, Okuda N, Saito N, Ogawa T, Machida R, Nomura S, Ôhara M, Haseyama M, Shimomura M.

Biomimetics (Basel). 2019 Jan 4;4(1). pii: E2. doi: 10.3390/biomimetics4010002.

2.

Author Correction: The Rho GTPase Rnd1 suppresses mammary tumorigenesis and EMT by restraining Ras-MAPK signalling.

Okada T, Sinha S, Esposito I, Schiavon G, López-Lago MA, Su W, Pratilas CA, Abele C, Hernandez JM, Ohara M, Okada M, Viale A, Heguy A, Socci ND, Sapino A, Seshan VE, Long S, Inghirami G, Rosen N, Giancotti FG.

Nat Cell Biol. 2019 Apr;21(4):534. doi: 10.1038/s41556-019-0288-3.

PMID:
30842593
3.

Significance of lung biopsy for the definitive diagnosis of lung nodules in breast cancer patients.

Matsuura K, Itamoto T, Noma M, Ohara M, Akimoto E, Doi M, Nishisaka T, Arihiro K, Kadoya T, Okada M.

Mol Clin Oncol. 2018 Feb;8(2):250-256. doi: 10.3892/mco.2017.1511. Epub 2017 Nov 24.

4.

Myasthenia Gravis Complicated with Peripheral T-cell Lymphoma, Not Otherwise Specified (PTCL-NOS), Following Thymectomy and Longstanding Tacrolimus Therapy.

Ohara M, Ozaki K, Ohkubo T, Yamada A, Numasawa Y, Tanaka K, Tomii S, Ishibashi S, Sanjo N, Yokota T.

Intern Med. 2018 Feb 15;57(4):601-604. doi: 10.2169/internalmedicine.9167-17. Epub 2017 Dec 21.

5.

Role of 18F-PET/CT in Predicting Prognosis of Patients With Breast Cancer After Neoadjuvant Chemotherapy.

Akimoto E, Kadoya T, Kajitani K, Emi A, Shigematsu H, Ohara M, Masumoto N, Okada M.

Clin Breast Cancer. 2018 Feb;18(1):45-52. doi: 10.1016/j.clbc.2017.09.006. Epub 2017 Sep 19.

PMID:
28993056
6.

Establishment of an orthotopic patient-derived xenograft mouse model using uveal melanoma hepatic metastasis.

Kageyama K, Ohara M, Saito K, Ozaki S, Terai M, Mastrangelo MJ, Fortina P, Aplin AE, Sato T.

J Transl Med. 2017 Jun 23;15(1):145. doi: 10.1186/s12967-017-1247-z.

7.

Comparison of visual assessment and image analysis in the evaluation of Ki-67 expression and their prognostic significance in immunohistochemically defined luminal breast carcinoma.

Arihiro K, Oda M, Ohara M, Kadoya T, Osaki A, Nishisaka T, Shiroma N, Kobayashi Y.

Jpn J Clin Oncol. 2016 Dec;46(12):1081-1087. Epub 2016 Aug 10.

PMID:
27511992
8.
9.

Prognostic impact of progesterone receptor status combined with body mass index in breast cancer patients treated with adjuvant aromatase inhibitor.

Ohara M, Akimoto E, Noma M, Matsuura K, Doi M, Kagawa N, Itamoto T.

Oncol Lett. 2015 Nov;10(5):3286-3292. Epub 2015 Aug 28.

10.

Establishment and Characterization of Orthotopic Mouse Models for Human Uveal Melanoma Hepatic Colonization.

Ozaki S, Vuyyuru R, Kageyama K, Terai M, Ohara M, Cheng H, Manser T, Mastrangelo MJ, Aplin AE, Sato T.

Am J Pathol. 2016 Jan;186(1):43-56. doi: 10.1016/j.ajpath.2015.09.011. Epub 2015 Nov 25.

11.
12.

The Rho GTPase Rnd1 suppresses mammary tumorigenesis and EMT by restraining Ras-MAPK signalling.

Okada T, Sinha S, Esposito I, Schiavon G, López-Lago MA, Su W, Pratilas CA, Abele C, Hernandez JM, Ohara M, Okada M, Viale A, Heguy A, Socci ND, Sapino A, Seshan VE, Long S, Inghirami G, Rosen N, Giancotti FG.

Nat Cell Biol. 2015 Jan;17(1):81-94. doi: 10.1038/ncb3082. Epub 2014 Dec 22. Erratum in: Nat Cell Biol. 2019 Apr;21(4):534.

13.

The efficacy and safety of preoperative chemotherapy with triweekly abraxane and cyclophosphamide followed by 5-Fluorouracil, epirubicin, and cyclophosphamide therapy for resectable breast cancer: a multicenter clinical trial.

Shigematsu H, Kadoya T, Masumoto N, Sasada T, Emi A, Ohara M, Kajitani K, Okada M.

Clin Breast Cancer. 2015 Apr;15(2):110-6. doi: 10.1016/j.clbc.2014.09.010. Epub 2014 Oct 2.

PMID:
25454688
14.

Endoscopy-assisted breast-conserving surgery for breast cancer patients.

Ozaki S, Ohara M.

Gland Surg. 2014 May;3(2):94-108. doi: 10.3978/j.issn.2227-684X.2013.12.04. Review.

15.

[Estimation of peritoneal dissemination in patients with unresectable advanced or recurrent colorectal cancer who underwent curative resection after combination chemotherapy].

Mizota S, Ikeda S, Yamauchi M, Imaoka Y, Mashima H, Okimoto S, Takakura Y, Noma M, Ohara M, Oishi K, Kohashi T, Fudaba Y, Ishimoto T, Matsugu Y, Nakahara H, Urushihara T, Shinozaki K, Itamoto T.

Gan To Kagaku Ryoho. 2014 May;41(5):595-600. Japanese.

PMID:
24917004
16.

[A case of triple-negative breast cancer responding to multidisciplinary treatment containing bevacizumab].

Noma M, Ohara M, Imaoka Y, Mashima H, Mizota S, Okimoto S, Takakura Y, Oishi K, Kohashi T, Ikeda S, Fudaba Y, Matsugu Y, Ishimoto T, Nakahara H, Urushihara T, Itamoto T, Doi M, Nishisaka T.

Gan To Kagaku Ryoho. 2014 Apr;41(4):483-6. Japanese.

PMID:
24743365
17.

Pathologic complete response after neoadjuvant chemotherapy in HER2-overexpressing breast cancer according to hormonal receptor status.

Tanioka M, Sasaki M, Shimomura A, Fujishima M, Doi M, Matsuura K, Sakuma T, Yoshimura K, Saeki T, Ohara M, Tsurutani J, Watatani M, Takano T, Kawabata H, Mukai H, Naito Y, Hirokaga K, Takao S, Minami H.

Breast. 2014 Aug;23(4):466-72. doi: 10.1016/j.breast.2014.03.008. Epub 2014 Apr 16.

PMID:
24742606
18.

Role of FDG-PET/CT in evaluating surgical outcomes of operable breast cancer--usefulness for malignant grade of triple-negative breast cancer.

Ohara M, Shigematsu H, Tsutani Y, Emi A, Masumoto N, Ozaki S, Kadoya T, Okada M.

Breast. 2013 Oct;22(5):958-63. doi: 10.1016/j.breast.2013.05.003. Epub 2013 Jun 10.

PMID:
23756383
19.

[A case of late recurrent breast cancer that responded to radiation therapy and cisplatin plus pemetrexed therapy].

Akimoto E, Ohara M, Noma M, Kamitsuna M, Nishizaka T, Itamoto T.

Gan To Kagaku Ryoho. 2013 Mar;40(3):371-4. Japanese.

PMID:
23507601
20.

Technical feasibility and cosmetic advantage of hybrid endoscopy-assisted breast-conserving surgery for breast cancer patients.

Ozaki S, Ohara M, Shigematsu H, Sasada T, Emi A, Masumoto N, Kadoya T, Murakami S, Kataoka T, Fujii M, Arihiro K, Okada M.

J Laparoendosc Adv Surg Tech A. 2013 Feb;23(2):91-9. doi: 10.1089/lap.2012.0224. Epub 2012 Dec 28.

PMID:
23272727

Supplemental Content

Loading ...
Support Center